168 related articles for article (PubMed ID: 34861679)
1. Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans.
Brandl A; Solimando AG; Mokhtari Z; Tabares P; Medler J; Manz H; Da Vià MC; Croci GA; Kurzwart M; Thusek S; Schneider T; Ebert R; Jakob F; Einsele H; Beilhack A
Blood Adv; 2022 Apr; 6(7):2195-2206. PubMed ID: 34861679
[TBL] [Abstract][Full Text] [Related]
2. MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer.
Lampis A; Hahne JC; Gasparini P; Cascione L; Hedayat S; Vlachogiannis G; Murgia C; Fontana E; Edwards J; Horgan PG; Terracciano L; Sansom OJ; Martins CD; Kramer-Marek G; Croce CM; Braconi C; Fassan M; Valeri N
Cell Death Differ; 2021 Oct; 28(10):2970-2982. PubMed ID: 34226680
[TBL] [Abstract][Full Text] [Related]
3. Junctional adhesion molecule C (JAM-C) dimerization aids cancer cell migration and metastasis.
Garrido-Urbani S; Vonlaufen A; Stalin J; De Grandis M; Ropraz P; Jemelin S; Bardin F; Scheib H; Aurrand-Lions M; Imhof BA
Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):638-649. PubMed ID: 29378216
[TBL] [Abstract][Full Text] [Related]
4. JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.
Solimando AG; Brandl A; Mattenheimer K; Graf C; Ritz M; Ruckdeschel A; Stühmer T; Mokhtari Z; Rudelius M; Dotterweich J; Bittrich M; Desantis V; Ebert R; Trerotoli P; Frassanito MA; Rosenwald A; Vacca A; Einsele H; Jakob F; Beilhack A
Leukemia; 2018 Mar; 32(3):736-743. PubMed ID: 29064484
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase.
McSherry EA; Brennan K; Hudson L; Hill AD; Hopkins AM
Breast Cancer Res; 2011 Mar; 13(2):R31. PubMed ID: 21429211
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings.
Leech AO; Vellanki SH; Rutherford EJ; Keogh A; Jahns H; Hudson L; O'Donovan N; Sabri S; Abdulkarim B; Sheehan KM; Kay EW; Young LS; Hill ADK; Smith YE; Hopkins AM
Breast Cancer Res; 2018 Nov; 20(1):140. PubMed ID: 30458861
[TBL] [Abstract][Full Text] [Related]
7. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
[TBL] [Abstract][Full Text] [Related]
8. JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide.
Xu PP; Sun YF; Fang Y; Song Q; Yan ZX; Chen Y; Jiang XF; Fei XC; Zhao Y; Leboeuf C; Li B; Wang CF; Janin A; Wang L; Zhao WL
Sci Rep; 2017 Aug; 7(1):7433. PubMed ID: 28785100
[TBL] [Abstract][Full Text] [Related]
9. Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific.
Naik MU; Naik UP
J Cell Sci; 2006 Feb; 119(Pt 3):490-9. PubMed ID: 16418218
[TBL] [Abstract][Full Text] [Related]
10. The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression.
Czubak-Prowizor K; Babinska A; Swiatkowska M
Mol Cell Biochem; 2022 Jan; 477(1):79-98. PubMed ID: 34533648
[TBL] [Abstract][Full Text] [Related]
11. Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus.
Kelly KR; Espitia CM; Zhao W; Wendlandt E; Tricot G; Zhan F; Carew JS; Nawrocki ST
Oncotarget; 2015 Dec; 6(38):41275-89. PubMed ID: 26513296
[TBL] [Abstract][Full Text] [Related]
12. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
[TBL] [Abstract][Full Text] [Related]
13. Junctional adhesion molecule-A, an epithelial-mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer.
Tian Y; Tian Y; Zhang W; Wei F; Yang J; Luo X; Zhou T; Hou B; Qian S; Deng X; Qiu Y; Yao K
Carcinogenesis; 2015 Jan; 36(1):41-8. PubMed ID: 25416560
[TBL] [Abstract][Full Text] [Related]
14. Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker for long-term repopulating hematopoietic stem cells.
Sugano Y; Takeuchi M; Hirata A; Matsushita H; Kitamura T; Tanaka M; Miyajima A
Blood; 2008 Feb; 111(3):1167-72. PubMed ID: 17986666
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling.
Peddibhotla SS; Brinkmann BF; Kummer D; Tuncay H; Nakayama M; Adams RH; Gerke V; Ebnet K
Mol Biol Cell; 2013 Apr; 24(7):933-44. PubMed ID: 23389628
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
17. Junctional adhesion molecule-A deletion increases phagocytosis and improves survival in a murine model of sepsis.
Klingensmith NJ; Fay KT; Swift DA; Bazzano JM; Lyons JD; Chen CW; Meng M; Ramonell KM; Liang Z; Burd EM; Parkos CA; Ford ML; Coopersmith CM
JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35819838
[TBL] [Abstract][Full Text] [Related]
18. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
Fong D; Spizzo G; Mitterer M; Seeber A; Steurer M; Gastl G; Brosch I; Moser P
Ann Surg Oncol; 2012 Dec; 19(13):4330-6. PubMed ID: 22549289
[TBL] [Abstract][Full Text] [Related]
19. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
20. Homing of human B cells to lymphoid organs and B-cell lymphoma engraftment are controlled by cell adhesion molecule JAM-C.
Doñate C; Ody C; McKee T; Ruault-Jungblut S; Fischer N; Ropraz P; Imhof BA; Matthes T
Cancer Res; 2013 Jan; 73(2):640-51. PubMed ID: 23221386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
